Detalles de la búsqueda
1.
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.
Br J Haematol
; 198(3): 535-544, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35438802
2.
A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure.
Haematologica
; 104(8): 1565-1571, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30733271
3.
Prospective evaluation of the effect of deferasirox on hematologic response in transfusion-dependent patients with low-risk MDS and iron overload.
Eur J Haematol
; 2018 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29719933
4.
Expression of embryonic stem cell markers in acute myeloid leukemia.
Tumour Biol
; 39(7): 1010428317716629, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28718379
5.
Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies.
Haematologica
; 102(4): 728-735, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28034993
6.
Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?
Ann Hematol
; 96(3): 363-371, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28011984
7.
Acute myeloid leukemia in the elderly (age 70 yr or older): long-term survivors.
Eur J Haematol
; 98(2): 134-141, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27717105
8.
Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 22(4): 723-730, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26718666
9.
A randomized phase II trial of azacitidine +/- epoetin-ß in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents.
Haematologica
; 101(8): 918-25, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27229713
10.
Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphoma.
Proc Natl Acad Sci U S A
; 110(6): 2306-11, 2013 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23345446
11.
HTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemia.
Retrovirology
; 11: 119, 2014 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25519886
12.
Human T lymphotropic virus type 1 increases T lymphocyte migration by recruiting the cytoskeleton organizer CRMP2.
J Immunol
; 188(3): 1222-33, 2012 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22227566
13.
Antiretroviral therapy promotes an inflammatory-like pattern of human T-cell lymphotropic virus type 1 (HTLV-1) replication in human immunodeficiency virus type 1/HTLV-1 co-infected individuals.
J Gen Virol
; 94(Pt 4): 753-757, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23239567
14.
Addition of suberoylanilide hydroxamic acid (Vorinostat) to azacitidine for patients with higher risk myelodysplastic syndromes and azacitidine failure: a phase II add-on study from the Groupe Francophone des Myelodysplasies.
Br J Haematol
; 180(5): 735-737, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27977052
15.
Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network.
J Clin Oncol
; 41(10): 1888-1897, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36455187
16.
HTLV-1 positive and negative T cells cloned from infected individuals display telomerase and telomere genes deregulation that predominate in activated but untransformed CD4+ T cells.
Int J Cancer
; 131(4): 821-33, 2012 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21717459
17.
Lenalidomide in lower-risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis-stimulating agents.
Br J Haematol
; 156(5): 619-25, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22211483
18.
Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors.
Blood
; 116(19): 3802-8, 2010 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-20587783
19.
Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies.
Haematologica
; 97(2): 213-8, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21993675
20.
Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
Blood
; 113(26): 6528-32, 2009 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-19411628